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Outbred, Hartley strain guinea pigs were fed purified diets varying only in their levels of vitamin D. The
amounts of vitamin D in the diets were adjusted to represent 0, 25, 50, 100, or 200%o of the recommended level
(1,180 IU/kg of body weight) for guinea pigs. In some experiments, half of the animals in each diet group were
vaccinated with Mycobacterium bovis BCG vaccine at the time the diets were introduced. Six weeks later, all
guinea pigs were infected by the respiratory route with a low dose of virulent M. tuberculosis H37Rv. Vitamin
D-deficient animals exhibited marked reductions in levels of the major vitamin D metabolite, 25-hydroxyvita-
min D3, in plasma. Altered vitamin D intake was accompanied by changes in antigen (purified protein
derivative)-induced, cell-mediated immune responses both in vivo (tuberculin hypersensitivity) and in vitro
(lymphoproliferation). Dermal tuberculin reactivity developed more slowly in vitamin D-deficient guinea pigs
but eventually achieved normal levels. The proliferation of splenocytes cultured with purified protein derivative
was suppressed by both deficiency and excess of dietary vitamin D. Vitamin D status did not affect the abilities
of naive guinea pigs to control primary, pulmonary tuberculosis, nor did it influence the protective efficacy of
BCG vaccination. We conclude that changes in dietary vitamin D are associated with alterations in some
cellular immune functions but may not be an important determinant of disease outcome in pulmonary
tuberculosis, as has been suggested previously.
There is a strong epidemiologic association between mal-
nutrition and infection with Mycobacterium tuberculosis in
humans (24). Among the dietary deficiencies which have
been implicated in the impaired response to tuberculosis in
humans are protein and vitamins A and C (12). Tuberculosis
is a major cause of morbidity and mortality in malnourished
children, which compose more than half of the pediatric
population in many developing countries (37). The reactiva-
tion of previous tuberculous infections in the elderly may
also be related to the deteriorating nutritional status of these
individuals (34). Additional populations at increased risk of
developing tuberculosis in which malnutrition is an underly-
ing condition include alcoholics, the homeless, and human
immunodeficiency virus-infected individuals (7, 31).
A potential role for vitamin D in resistance to tuberculosis
was suggested by several anecdotal observations. In the
preantibiotic era, tuberculosis patients were sent to high
elevations in Europe or to the sunny southwestern part of
the United States. Clinical improvement may have been the
result of increased exposure to sunlight leading to enhanced
synthesis of vitamin D in the skin (9). Vitamin D (either
ingested or synthesized in the skin) is transported to the
liver, where it is hydroxylated by vitamin D-25 hydroxylase,
forming 25-hydroxyvitamin D3 (25-OH-D), the most abun-
dant metabolite found in the circulation (23). Further metab-
olism of 25-OH-D by several types of cells, including acti-
vated macrophages, results in the production of 1,25
(OH)2D3, or calcitriol. Calcitriol is now well recognized as a
potent immunoregulatory hormone (26, 39). Increased levels
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of calcitriol in serum have been demonstrated with patients
with both tuberculosis and hypercalcemia (4) and with
anephric patients with tuberculosis (11). Alveolar lavage
cells from a patient with pulmonary tuberculosis produced
1,25(OH)2D3 (6), and high concentrations of calcitriol and
gamma interferon (IFN-y) were reported in pleural fluid of
patients with tuberculous pleuritis (2). Pleural fluid-based
macrophages could be the source of calcitriol production
which may be regulated by IFN--y (1).
Recently, investigators have examined the role of vitamin
D in resistance against tuberculosis by employing an in vitro
model involving cultured macrophages infected with M.
tuberculosis (8). Two groups have documented an inhibitory
effect of calcitriol in vitro on the replication of mycobacteria
within cultured human monocytes (10, 29, 30). In contrast, a
similar protective effect of calcitriol was not observed in
cultured murine macrophages infected with M. tuberculosis
(27, 28). In addition to these effects in vitro, altered mac-
rophage functions have also been reported for vitamin
D-deficient mice and humans (3, 36). The effect of dietary
vitamin D, as either a deficiency or a supplement, on
resistance to tuberculosis has not been determined.
For several years, we have studied the impact of dietary
protein deficiency on M. tuberculosis BCG vaccine efficacy
and tuberculosis immunity in a guinea pig model involving
infection by the respiratory route with virulent M. tubercu-
losis (16-18). This model has been previously demonstrated
to mimic important aspects of the pathogenesis of tubercu-
losis in humans (33). Recently, we examined the role of
dietary vitamin D in the pathogenesis of pulmonary tuber-
culosis in this animal model.
(This study was previously presented in part [1Sa]).
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MATERIALS AND METHODS
Experimental animals. Specific-pathogen-free, outbred al-
bino guinea pigs (Hartley-COBS, Crl:(HA)Br; Charles River
Breeding Laboratories, Inc., Wilmington, Mass.) weighing
initially between 250 and 400 g were obtained for this study.
The animals were housed individually in polycarbonate
cages with stainless-steel grid floors and feeders and were
allowed food and water ad libitum. Each animal was ran-
domly assigned to an experimental diet and vaccination
treatment group when appropriate. Body weights were re-
corded weekly throughout the experiment.
Experimental diets. The five experimental diets, represent-
ing different concentrations of vitamin D, were obtained
from a commercial source (Dyets, Inc., Bethlehem, Pa.) and
formulated to our specifications. The diets were isocaloric
and identical in nutrient content except for their concentra-
tions of vitamin D. The composition of the basal control diet
has been published previously (18), and it meets the recom-
mended nutrient requirements for guinea pigs (21). The level
of vitamin D in the diets varied from none (0 IU/kg of body
weight) to 25% (295 IU/kg), 50% (590 IU/kg), 100% (1,180
IU/kg), or 200% (2,360 IU/kg) of the recommended dietary
content for guinea pigs. Prior to the initiation of experimen-
tal diets, guinea pigs were weaned from commercial chow by
being fed a mixture of 50% powdered control diet and 50%
ground chow (Ralston Purina, St. Louis, Mo.) for 2 weeks.
Animals were given fresh food daily.
BCG vaccination. In some experiments, 1 week prior to
the implementation of experimental diets, half of the guinea
pigs in each diet treatment were vaccinated with M. bovis
BCG vaccine (Copenhagen 1331; Statens Seruminstitut,
Copenhagen, Denmark). The vaccine was prepared by re-
constituting a vial of lyophilized BCG vaccine in sterile
physiological saline. Each animal was injected subcutane-
ously in its left inguinal region with 0.1 ml of saline suspen-
sion which contained approximately 103 viable organisms.
Respiratory infection. Virulent M. tuberculosis H37Rv
(ATCC 27294) was obtained from the American Type Cul-
ture Collection, Rockville, Md., and prepared for long-term
storage as single-cell suspensions at -70°C (15). A single lot
of culture frozen since 1988 was used for all of these
experiments. The challenge inoculum was thawed and di-
luted just prior to infection. All animals were infected via the
respiratory route with an aerosol chamber described previ-
ously (40). The infecting inoculum of viable M. tuberculosis
H37Rv introduced into the nebulizer was adjusted empiri-
cally to result in the inhalation and retention of 5 to 10 viable
organisms per animal. The infection was performed in a BL3
biohazard facility designed for use with class 3 human
pathogens. Exposure of groups of guinea pigs, selected
randomly from the diet groups, resulted in uniform, repro-
ducible infections of all animals with virulent mycobacteria.
Following infections, guinea pigs were maintained in indi-
vidual stainless-steel cages with water bottles and filter
bonnets in the BL3 biohazard facility.
Delayed hypersensitivity skin test. One day before being
sacrificed, the animals were skin tested with purified protein
derivative (PPD) (PPD-RT23; Statens Seruminstitut). The 2
doses used consisted of 0.1 ml containing 5 or 100 tuberculin
units (TU) of PPD. Each animal was injected intradermally
on a shaved area on the right side of the abdomen. Twenty-
four hours later, the skin reactions were measured with a
plastic ruler, and the mean diameter of induration was
recorded in millimeters.
Necropsy procedure. Guinea pigs were killed at intervals
following pulmonary infections by the intraperitoneal injec-
tion of approximately 2 ml of pentobarbital sodium solution
(Sleepaway; Fort Dodge Laboratories, Inc., Fort Dodge,
Iowa). A sample of blood was taken immediately by cardiac
puncture. The thoracic and abdominal cavities were opened,
and the spleen and the entire right lower lung lobe were
aseptically removed. Exactly one-half of the spleen (by
weight) of each animal was placed in a sterile culture tube
containing 3 ml of RPMI 1640 medium (Irvine Scientific,
Santa Ana, Calif.) supplemented with 10% fetal bovine
serum (Hazleton, Lenexa, Kans.), 100 U of penicillin per ml,
100 pg of streptomycin per ml, 2 mM L-glutamine (Irvine
Scientific), and 10 ,uM 2-mercaptoethanol (Aldrich Chemical
Company, Inc., Milwaukee, Wis.). The other half of the
spleen (by weight) and the lung lobe were homogenized
separately in 4.5 ml of sterile saline with Teflon-glass ho-
mogenizers. The number of viable M. tuberculosis H37Rv
organisms in each organ was determined by inoculating
appropriate dilutions of individual organ homogenates onto
duplicate plates of Middlebrook 7H10 agar (Difco Laborato-
ries, Detroit, Mich.). The colonies were counted after being
incubated for 3 weeks at 37°C. Data were expressed as the
mean log1o number of viable organisms present in each
portion of tissue.
Lymphocyte blastogenesis. Half of the spleen was homog-
enized in RPMI 1640 (supplemented as described above) in a
Ten Broeck glass homogenizer. The cells were passed
through a stainless-steel wire mesh, resulting in a single-cell
suspension. Cell viability was determined by trypan blue
exclusion. A 100-,ul sample of lymphocyte suspension con-
taining 2 x 105 viable spleen cells per well was cultured in
96-well microtiter plates (flat-bottom Microtest III plate;
Becton Dickinson & Co., Oxnard, Calif.). Triplicate cultures
received 100 Il of one of the following: 10 Rg of concanava-
lin A per ml (Sigma, St. Louis, Mo.), 25 or 12.5 ,ug of PPD
(PPD-RT40; Statens Seruminstitut) per ml, or medium. The
cell cultures were incubated for 4 days at 37°C in an
atmosphere of 5% CO2 in air. After incubation, 50 ,ul of
tissue culture medium containing 1.0 ,Ci of tritiated thymi-
dine (New England Nuclear, North Billerica, Mass.) was
added per well, and the cells were cultured for an additional
6 h. The cultures were harvested onto fiberglass filters with
a multiple automated cell harvester. The incorporated radio-
activity was measured with a liquid scintillation counter (LS
8000; Beckman Instruments, Inc., Irvine, Calif.). The results
were expressed as the net uptake of tritiated thymidine,
defined as the difference between the mean counts per
minute in triplicate stimulated cultures and those in triplicate
unstimulated cultures of the same animal's cells.
25-hydroxyvitamin D assay. Two milliliters of the blood
sample was centrifuged separately to obtain the plasma used
to measure vitamin D metabolite levels. A commercial
25-OH-D 3H-assay system was used (Amersham Corpora-
tion, Arlington Heights, Ill.). The assay is based on compe-
tition between unlabelled 25-OH-D (in the serum sample)
and tritium-labelled 25-OH-D for binding to the 25-hydroxy-
vitamin D-binding protein from sheep serum. The assay was
performed exactly as defined in the supplier's instructions,
which accompanied the kit. A standard curve was con-
structed with concentrations of purified 25-OH-D ranging
from 2 to 32 ng/ml. The results were expressed as nanograms
per milliliter of guinea pig plasma.
Analysis of variance was utilized to test the effects of
dietary vitamin D content on the dependent variables mea-
sured. When significant treatment effects were indicated,
differences between means were assessed by the new mul-
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TABLE 1. Influence of dietary vitamin D on growth and
25-OH-D concentrations in plasma
Concn of dietary Change in body Concn in pll,sma
vitamin D (IU/kg) wt (g)a (ng/ml)
2,360 130 ± 7 17.3 ± 2.4*
1,180 121 ± 8 16.2 ± 3.1*
590 129 ± 10 10.5 ± 1.4**
295 128 ± 7 7.0 ± 0.9***
0 120 ± 11 6.3 ± 1.8***
a Data are the means ± standard errors of the mean for 11 to 13 animals per
treatment.
b Values in the same column with different numbers of asterisks are
significantly different from one another (P < 0.05).
tiple-range test of Duncan (35). A 95% confidence level was
set for all tests.
RESULTS
Table 1 illustrates the influence of dietary vitamin D levels
on growth and the concentration of the major circulating
metabolite, 25-OH-D, in plasma in guinea pigs maintained
for 6 weeks on their different diets. Diet had no effect on
weight gain, indicating that food intake was essentially the
same in all groups. Likewise, body weight was unaffected by
diet in guinea pigs infected with virulent M. tuberculosis for
the last 6 weeks of a 12-week diet treatment (data not
shown). However, dietary vitamin D levels did exert a
significant influence on the concentration of 25-OH-D in the
circulation. Guinea pigs maintained for 6 weeks on the three
deficient diets exhibited statistically significant reductions in
levels of 25-OH-D in plasma. Supplementation with twice
the recommended level did not result in a significant effect
on this vitamin D metabolite.
The effect of dietary vitamin D on the abilities of BCG-
vaccinated guinea pigs to mount delayed hypersensitivity
reactions is presented in Table 2. Animals vaccinated 6
weeks prior to pulmonary challenge with virulent M. tuber-
culosis H37Rv were skin tested with 2 doses of PPD either 3
or 6 weeks postchallenge. As expected, tuberculin reactions
were larger in response to the 100-TU dose and increased
between 3 and 6 weeks after infection in all groups. Both the
vitamin-deficient and -supplemented groups exhibited signif-
icantly reduced skin reaction sizes at both intervals. This
dietary effect was most striking with the 5-TU dose of
tuberculin.
This suppressive effect of altered vitamin D intake on
PPD-induced immune reactions in vivo was mirrored by the
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FIG. 1. Proliferative response to PPD (25 ,ug/ml) in splenocytes
from guinea pigs vaccinated (V) or not vaccinated (NV) with BCG
and maintained for 12 weeks on diets differing only in their levels of
vitamin D; animals had been challenged 6 weeks earlier with M.
tuberculosis H37Rv by the respiratory route. Data are means
standard errors of the mean of the net uptake of thymidine in
triplicate cultures derived from four to six animals per treatment.
Asterisks denote the statistically significant effect of diet within
vaccination (*) or vaccination within diet (**) at P < 0.05.
proliferative responses of lymphocytes cultured with PPD in
vitro (Fig. 1). Splenocytes were prepared from BCG-vacci-
nated and nonvaccinated guinea pigs fed diets containing
normal or twice the normal level of vitamin D or no vitamin
D for 12 weeks. All animals had been infected with virulent
M. tuberculosis H37Rv by the respiratory route for the last
6 weeks of the dietary treatment. Because of their previous
sensitization to mycobacterial antigens, splenocytes from
BCG-vaccinated animals consuming the control diet prolif-
erated more extensively than did cells from animals who
were developing reactivity to their primary, pulmonary
infections. Within the BCG-vaccinated group, vitamin D
supplementation resulted in a slight but statistically signifi-
cant decline in PPD-induced proliferation. Absence of vita-
min D also resulted in cells capable of responding at only
one-third the normal levels (P < 0.05). In contrast, the
reverse trend was observed among previously nonvacci-
nated guinea pigs, with vitamin D-deficient animals exhibit-
ing increased proliferation. The dietary effect did not reach
statistical significance in the nonvaccinated group.
The influence of supplementation with or absence of
TABLE 2. Influence of dietary vitamin D on delayed hypersensitivity to PPD in guinea pigs challenged by
the respiratory route with virulent M. tuberculosis H37Rv
Diam of induration (mm)a at:
Concn of dietary 6 wk
vitamin D (IU/kg) 3 wk
5 TU 100 TU 5 TU 100 TU
2,360 10.7 ± 2.2** 14.2 ± 2.9** 7.8 ± 1.8** 14.6 ± 2.2**
1,180 13.6 ± 1.0* 18.5 + 1.2* 12.3 ± 0.8* 20.1 ± 0.9*
590 NDb 12.1 + 1.9** ND 15.3 ± 2.1**
295 ND 10.3 + 2.0** ND 15.8 ± 1.9**
0 10.0 ± 1.0** 13.8 ± 1.8** 5.6 ± 2.1** 14.8 ± 1.4**
a Data are the means ± standard errors of the mean for four to six animals per treatment per interval. Values in the same column with different numbers of
asterisks are significantly different from one another (P < 0.05).
b ND, not determined.
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FIG. 2. Numbers of viable M. tuberculosis H37Rv organisms
recovered from the lungs of BCG-vaccinated (closed symbols) and
nonvaccinated (open symbols) guinea pigs maintained on diets
containing either 2,360 (circles), 1,180 (squares), or 0 (triangles) IU
of vitamin D per kg. Data are the means standard errors of the
mean for four to five animals per treatment per interval. The vaccine
effect is statistically significant for all diets at 6 weeks (P < 0.01).
dietary vitamin D on BCG vaccine-induced or innate resis-
tance to pulmonary infection with virulent M. tuberculosis
was assessed by quantitative culture of viable mycobacteria
from the lungs and spleens of guinea pigs at 3 and 6 weeks
following infection. These intervals were chosen, on the
basis of a detailed knowledge of the time course of infection
in this model (40), to represent a point early after the onset
of acquired resistance (3 weeks) and a second point after the
maximum level of resistance had been attained (6 weeks).
Figure 2 demonstrates that BCG vaccination allowed guinea
pigs in all three diet groups to effectively control the accu-
mulation of viable mycobacteria in their lungs between 3 and
6 weeks postchallenge. The vaccine effect was highly statis-
tically significant (P < 0.01). However, dietary vitamin D
levels exerted no demonstrable effect on the level of pulmo-
nary infection in either vaccinated or nonvaccinated groups.
The protective effect of BCG was even more striking in the
spleen (Fig. 3), in which a 4 log1o difference in infection was
observed (P < 0.001). Again, dietary vitamin D was not a
significant determinant of disease resistance in either vacci-
nated or nonvaccinated guinea pigs.
DISCUSSION
The role of vitamin D in the pathogenesis of tuberculosis
remains controversial. On the basis of epidemiological rela-
tionships and largely anecdotal clinical observations, one
can build a circumstantial case for a protective role of
vitamin D in tuberculosis (9, 14). It is clear that the meta-
bolically active form of vitamin D, 1,25(OH)2D3, or cal-
citriol, is capable of synergizing with cytokines such as
IFN-y to endow cultured human macrophages with the
ability to retard the intracellular growth of Mycobacterium
avium and M. tuberculosis in vitro (5, 10, 29, 30). In
contrast, similar experiments conducted with murine mac-
rophages infected with M. tuberculosis failed to demonstrate
a protective effect for calcitriol (27, 28). Recent studies have
begun to unravel the interactions between calcitriol and
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FIG. 3. Numbers of viable M. tuberculosis H37Rv organisms
recovered from the spleens of BCG-vaccinated (closed symbols) and
nonvaccinated (open symbols) guinea pigs maintained on diets
containing either 2,360 (circles), 1,180 (squares), or 0 (triangles) IU
of vitamin D per kg. Data are the means ± standard errors of the
mean for four to five animals per treatment per interval. The vaccine
effect is statistically significant for all diets at six weeks (P < 0.001).
cytokines such as interleukin 2 (IL-2), IL-6, tumor necrosis
factor alpha, and others at the cellular and molecular levels
(19, 20, 25, 38). However, no study published to date has
examined the effect of manipulating vitamin D levels in vivo
on resistance to pulmonary tuberculosis.
The guinea pig model chosen for these experiments has
been devised to mimic human pulmonary tuberculosis in
many fundamental ways, ensuring the biological relevance
of the observations made with this system (33). The model
has been employed previously to study the impact of dietary
protein and zinc deficiencies on cellular immune reactivity
and acquired resistance to infection with virulent M. tuber-
culosis (16-18). In the present study, we were able to
produce significant reductions in circulating concentrations
of the principal metabolite of vitamin D, 25-OH-D, by
lowering the dietary content to 50% or less of the recom-
mended allowance for guinea pigs (Table 1). Although one
might argue that 25-OH-D is not the immunologically active
form, levels of this metabolite in plasma are widely accepted
as being the best measure of vitamin D status (23). In fact,
the reductions in the levels of 25-OH-D in plasma in this
study are quite similar to the levels in tissue published
recently by Sergeev et al. (32) for vitamin D-depleted guinea
pigs. Since we did not actually assess the levels of
1,25(OH)2D3 in the plasma of our guinea pigs, any conclu-
sion regarding the effect of our diets on this active metabolite
must be considered tentative. However, we believe that the
vitamin D-deficient diets, especially the diet containing no
vitamin D, had significant biological effects on vitamin D
status in our guinea pigs. On the other hand, doubling the
recommended level of this vitamin had no measurable effect
on concentrations of 25-OH-D in plasma (Table 1).
Although much of the previous research on the relation-
ship between vitamin D and tuberculosis in vitro has focused
on the macrophage, there is evidence that vitamin D status
can influence lymphocytes directly and indirectly (26, 38,
39). We observed that antigen (PPD)-induced lymphoprolif-
VOL. 61, 1993
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eration was significantly affected by both excesses of and
deficiencies in dietary vitamin D (Fig. 1) in previously
BCG-vaccinated guinea pigs challenged with virulent M.
tuberculosis H37Rv. Interestingly, no such dietary effect
was observed in animals responding to mycobacterial anti-
gens for the first time. Calcitriol has been observed to
depress both antigen- and mitogen-driven lymphoprolifera-
tion when added to cultures in vitro (26, 38). This inhibition
could be due to either suppression of the autocrine IL-2 loop
(25) or reduced levels of IL-1 produced by accessory cells
(20). These mechanisms could explain the modest but signif-
icant reduction in PPD-induced proliferation in guinea pigs
fed a twofold excess of vitamin D. This requires the assump-
tion that levels of calcitriol in tissue and, more importantly,
calcitriol receptors on lymphocytes are increased in the
excess group. No published studies have reported the effect
of vitamin D deficiency on lymphoproliferation, but our
results suggest that the dose-response curve has an opti-
mum, with proliferation decreasing on both sides.
The effects of dietary vitamin D excess and depletion on
the delayed hypersensitivity response to PPD (Table 2)
mirrored the proliferation data. At both intervals postchal-
lenge with virulent mycobacteria (3 and 6 weeks) and with
both doses of PPD (5 and 100 TU), the size of the dermal
reaction was significantly greater in the group fed the optimal
vitamin D level (1,180 IU/kg) than in either the group fed a
twofold excess of or the group fed no vitamin D. Of course,
more than just antigen-induced lymphocyte proliferation is
involved in the development of delayed hypersensitivity. A
variety of nonspecific inflammatory mediators are also re-
quired for the expression of an indurated dermal response.
In addition to the effects of calcitriol on IL-1 and IL-2 noted
above, investigators have reported that the production and
function of IL-6 is inhibited by high levels of calcitriol in
vitro (19). IL-6 is a proinflammatory cytokine produced
principally by monocyte-macrophages, and its inhibition in
the vitamin D excess group could explain the reduction in
PPD skin test size observed by us. On the other hand,
treatment with calcitriol at physiological levels in vitro
augments the chemotactic response of human monocytes
(13). Thus, a presumed reduction in calcitriol levels in tissue
in the vitamin D-deprived group might have impaired the
migration of monocytes into the developing PPD reaction
and resulted in a smaller response.
The most important implication from the previous work
with vitamin D in vitro in human phagocytes infected with
mycobacteria is that vitamin D metabolites synergize with
cytokines (e.g., IFN-,y) to induce resistance in cultured
macrophages (5, 8, 10, 29, 30). Calcitriol has been previously
demonstrated to contribute to the in vitro activation of
murine alveolar macrophages and their fusion into multinu-
cleated giant cells, a hallmark of the granulomatous response
in tuberculosis (38). However, other investigators have
observed no protective role for calcitriol, with or without
cytokines, in the antimycobacterial activities of cultured
murine macrophages (27, 28). It has been previously sug-
gested that this apparent discrepancy between the responses
of murine and human macrophages to calcitriol must repre-
sent a fundamental biological difference in the roles of
vitamin D in mice and humans (28). However, there are a
number of other differences between these two studies
which could account for the observed variation in calcitriol
effect, including the source and state of maturation of the
macrophages employed. Since we did not test the effect of
vitamin D on the antimycobacterial properties of guinea pig
cells in vitro, it is impossible to know whether the results
would have approximated those observed in human or
murine cells. Nevertheless, the extrapolation of these in
vitro observations to the living host must be considered quite
tenuous. Some of the antimycobacterial effects in vitro
required levels of calcitriol which were clearly orders of
magnitude higher than physiological concentrations (8). The
in vitro culture systems employed were admittedly some-
what artifactual. The clinical reports that dietary vitamin D
might influence resistance to tuberculosis were not well
founded in carefully controlled trials with humans or animals
(9, 12, 14).
No previous studies had addressed the potential effect of
vitamin D on the ability to protect against tuberculosis by
BCG vaccination. Thus, we believe that the experiments
described here represent the first rigorous test of the hypoth-
esis in a highly relevant model of pulmonary tuberculosis.
Our results are reasonably unequivocal. No difference in
resistance to primary, pulmonary infections with a low dose
of virulent M. tuberculosis H37Rv was observed in guinea
pigs fed a twofold excess of or deprived of dietary vitamin D.
No dietary effect was seen either on the accumulation of
virulent mycobacteria in the lungs (Fig. 2) or on the bacil-
lemic phase of the disease, as reflected in mycobacterial
loads in the spleen (Fig. 3). Note that in this guinea pig
model, levels of viable mycobacteria in the lungs represent
events occurring at the primary lesions, while spleen counts
result both from hematogenous dissemination from the pri-
mary lung tubercles and from growth of the organism with
the spleen itself. This mimics exactly what is known to occur
in human pulmonary tuberculosis. Bacterial loads in the
spleen were no higher than counts in the lung (Fig. 2 and 3).
Previous experiments with this model have demonstrated
convincingly that the ultimate outcome in guinea pigs (i.e.,
percent mortality and mean time to death) correlates statis-
tically with bacterial loads in the lungs (40). Furthermore,
guinea pigs dying from such infections several months
postchallenge apparently die of pulmonary complications.
For these reasons, we believe that this model has a high
likelihood of predicting events which may occur in human
pulmonary tuberculosis (33). Guinea pigs vaccinated with
BCG vaccine 6 weeks prior to pulmonary challenge with M.
tuberculosis H37Rv exhibited solid resistance, as evidenced
by 100-fold reductions of viable mycobacteria in the lungs
(Fig. 2) and 10,000-fold reductions in splenic bacterial loads
(Fig. 3). Altered dietary vitamin D intake had no effect on
BCG vaccine efficacy in either tissue.
In conclusion, diets varying widely in vitamin D content
exerted significant effects on the principal circulating metab-
olite, 25-OH-D, and on selected antigen (PPD)-induced
immune functions in vivo and in vitro. However, these diets
did not alter the resistance of either naive or BCG-vacci-
nated guinea pigs to pulmonary infections with virulent M.
tuberculosis H37Rv. It is possible that levels of the crucial
immunomodulatory metabolite, calcitriol, in tissue were not
influenced significantly by our diets, although we believe
that this is unlikely. We are currently testing that hypothesis
with a guinea pig model of tuberculous pleurisy by measur-
ing vitamin D metabolites in pleural fluid (2, 22). Likewise,
the dietary insult may have been too short to affect disease
resistance significantly. However, we have previously ob-
served marked alterations in disease resistance after a sim-
ilar period of moderate protein deficiency with this model
(16, 17). On the basis of the results reported here, we must
conclude that vitamin D status appears not to be a determi-
nant of resistance to pulmonary tuberculosis in the guinea
pig model.
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